Boehringer Ingelheim

Boehringer Ingelheim is a global, research-driven pharmaceutical company that focuses on developing innovative therapies for some of the world's most challenging health conditions. Founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany, the company has grown to become one of the world's 20 leading pharmaceutical corporations.

History[edit | edit source]

Boehringer Ingelheim was established in 1885 by Albert Boehringer. The company initially produced lactic acid for use in the food industry, but quickly expanded into pharmaceuticals. Over the years, Boehringer Ingelheim has been responsible for the development and production of several significant pharmaceutical drugs.

Research and Development[edit | edit source]

Boehringer Ingelheim's research and development efforts are focused on four main therapeutic areas: respiratory diseases, cardiovascular diseases, oncology, and immunology. The company is committed to discovering and developing innovative medicines that help improve the lives of patients.

Products[edit | edit source]

Boehringer Ingelheim's product portfolio includes a wide range of prescription medicines and consumer healthcare products. Some of the company's most well-known products include Pradaxa, a blood thinner, and Spiriva, a bronchodilator for the treatment of chronic obstructive pulmonary disease (COPD).

Corporate Responsibility[edit | edit source]

Boehringer Ingelheim is committed to corporate responsibility and sustainability. The company's corporate responsibility initiatives focus on social, economic, and environmental sustainability.